Diego Lucero

ORCID: 0000-0003-2833-5681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Liver Disease Diagnosis and Treatment
  • Lipoproteins and Cardiovascular Health
  • Lipid metabolism and disorders
  • Cancer, Lipids, and Metabolism
  • Adipose Tissue and Metabolism
  • Atherosclerosis and Cardiovascular Diseases
  • Birth, Development, and Health
  • Diet and metabolism studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Diet, Metabolism, and Disease
  • Plasma Diagnostics and Applications
  • Cardiovascular Disease and Adiposity
  • Trace Elements in Health
  • Fatty Acid Research and Health
  • Health and Lifestyle Studies
  • Lipid metabolism and biosynthesis
  • Cellular transport and secretion
  • Cardiovascular Health and Disease Prevention
  • Dialysis and Renal Disease Management
  • Genetics, Bioinformatics, and Biomedical Research
  • Astro and Planetary Science
  • Natural Products and Biological Research
  • Spacecraft and Cryogenic Technologies
  • Planetary Science and Exploration

National Heart Lung and Blood Institute
2015-2025

National Institutes of Health
2015-2025

London School of Hygiene & Tropical Medicine
2025

University of Buenos Aires
2010-2019

Instituto de Química y Fisicoquímica Biológicas
2016-2019

Sandia National Laboratories California
2018

Advanced Materials Enterprises (China)
2018

Centro Científico Tecnológico - San Juan
2017

Institute for Atherosclerosis Research
2017

Sandia National Laboratories
2016

Increased small dense low-density lipoprotein-cholesterol (sdLDL-C) is a risk factor for atherosclerotic cardiovascular disease (ASCVD) but typically requires advanced lipid testing. We describe two new equations, first one calculating large buoyant LDL-C (lbLDL-C), based only upon results from the standard panel, and second sdLDL-C.Equations sdLDL-C lbLDL-C were generated with least-squares regression analysis using direct Denka assay as reference (n = 20 171). was assessed risk-enhancer...

10.1093/clinchem/hvab048 article EN public-domain Clinical Chemistry 2021-03-10

Introduction The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have ability to potentially affect cells, whereas curcumin is a known natural polyphenol with antioxidant anti-inflammatory properties. Aims This study was designed evaluate pro-inflammatory pro-oxidant effects leptin cells from patients NAFLD corroborate modulatory its preventive properties against progression using...

10.1371/journal.pone.0172900 article EN cc-by PLoS ONE 2017-03-03

Health professionals are burn out syndrome prone occupational group. In Ethiopia there limited evidences about burnout and work related determinant factors resulting in Burnout syndrome. Therefore, this study aimed to determine the prevalence of associated among health working university hospitals found Sidama region Southern 2023. An institution based multi-center cross-sectional was conducted on 362 three hospital from February 15 30, Study participants were recruited using Simple random...

10.1186/s12913-025-12437-x article EN cc-by-nc-nd BMC Health Services Research 2025-03-01

Background: Current lipid-lowering drugs reduce low-density lipoprotein (LDL) cholesterol by enhancing the LDL receptor (LDLR) pathway and are relatively ineffective in patients with Familial Hypercholesterolemia (FH) due to a dysfunctional LDLR. Angiopoietin-like 3 (ANGPTL3) inhibitors FH through an uncharacterized, LDLR-independent that requires endothelial lipase (EL). Kinetic studies showed ANGPTL3 directly enhanced catabolism; however, EL's role this remains unclear. Here, we aim...

10.1101/2025.03.02.640965 preprint EN public-domain bioRxiv (Cold Spring Harbor Laboratory) 2025-03-10

Hepatic lipase is a lipolytic enzyme mostly synthesized and localized at the surface of liver sinusoidal capillaries, which hydrolyses triglycerides phospholipids intermediate density, large low density (LDL) high lipoproteins. activity increased in insulin resistant states. Non-alcoholic fatty disease (NAFLD) characterized by resistance. However, present, no data are available regarding behaviour hepatic with regard to degree steatosis. Our aim was evaluate NAFLD patients its relationship...

10.1002/dmrr.2312 article EN Diabetes/Metabolism Research and Reviews 2012-04-27

Background: Qualitative lipoprotein changes, such as an increase in fasting remnants, are reported subclinical hypothyroidism (SCH). It was hypothesized that changes due to reduced hepatic lipase (HL) activity SCH: HL is enzyme regulated by thyroid hormones, and involved the degradation of triglyceride (TG)-rich remnants. This study aimed quantify remnant-like lipoproteins (RLP), small dense LDL (sdLDL), women with SCH, assess these parameters after levothyroxine replacement therapy....

10.1089/thy.2015.0140 article EN Thyroid 2016-02-03

Objective— To assess the phospholipase activity of endothelial (EL) and hepatic lipase (HL) in postheparin plasma subjects with metabolic syndrome (MS)/obesity their relationship atherogenic antiatherogenic lipoproteins. Additionally, to evaluate lipoprotein (LPL) HL as triglyceride (TG)-hydrolyses complete analyses SN1 lipolytic enzymes same patient. Approach Results— Plasma EL, HL, LPL activities were evaluated 59 patients MS 36 controls. A trend toward higher EL was observed MS. increased...

10.1161/atvbaha.113.303027 article EN Arteriosclerosis Thrombosis and Vascular Biology 2014-01-24

ApoB-100 is a member of large lipid transfer protein superfamily and one the main apolipoproteins found on low-density lipoprotein (LDL) very (VLDL) particles. Despite its clinical significance for development cardiovascular disease, there limited information apoB-100 structure. We have developed novel method based “divide conquer” algorithm, using PSIPRED software, by dividing into five subunits 11 domains. Models each domain were prepared I-TASSER, DEMO, RoseTTAFold, Phyre2, MODELLER....

10.3390/ijms231911480 article EN International Journal of Molecular Sciences 2022-09-29

The close association between nonalcoholic fatty liver and insulin resistance is now widely recognized. While the former characterized by excessive intrahepatic triglyceride accumulation, latter induces overproduction of very-low-density lipoprotein (VLDL) particles. It has not been well elucidated whether these apparently opposite mechanisms impact on VLDL characteristics or not. aim present study was to evaluate secretion features resulting from in rats fed a sucrose-rich diet (SRD, i.e....

10.1159/000276596 article EN Annals of Nutrition and Metabolism 2010-01-01

Could supplementation with n-3, n-6 and n-9 fatty acids prevent atherogenic alterations of VLDL produced in insulin-resistance?

10.1039/c7fo00252a article EN Food & Function 2017-01-01

A significant proportion of patients with elevated LDL and a clinical presentation familial hypercholesterolemia do not carry known genetic mutations associated hypercholesterolemia, such as defects in the receptor. To identify new genes involved cellular uptake LDL, we developed novel whole-genome clustered regularly interspaced short palindromic repeat-Cas9 KO screen HepG2 cells. We identified transgelin (TAGLN), an actin-binding protein, potentially gene endocytosis. In silico validation...

10.1016/j.jlr.2021.100160 article EN cc-by Journal of Lipid Research 2021-12-10

Abstract Background Matrix metalloproteinases ( MMP s), especially ‐2 and ‐9, have been identified in atherosclerotic plaques directly associated with plaque remodelling vulnerability. Cardiovascular disease (CVD) is related to insulin resistance IR ) obesity, characterized by changes plasma levels of inflammatory markers, such as adiponectin C‐reactive protein CRP ). Our aim was evaluate the impact both proteins on ‐9 behaviour individuals . Materials methods Plasma activity, hs‐...

10.1111/eci.12328 article EN European Journal of Clinical Investigation 2014-08-21

We sought to explore biomarkers of coronary atherosclerosis in an unbiased fashion.We analyzed 665 patients (mean ± SD age, 56 11 years; 47% male) from the GLOBAL clinical study (NCT01738828). Cases were defined by presence any discernable atherosclerotic plaque based on comprehensive cardiac computed tomography (CT). De novo Bayesian networks built out 37,000 molecular measurements and 99 conventional per patient examined potential causality specific biomarkers.Most highly ranked gradient...

10.3389/fcvm.2022.960419 article EN cc-by Frontiers in Cardiovascular Medicine 2023-01-04
Coming Soon ...